Cargando…

Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns

Follicular lymphoma (FL) accounts for ∼20% of all new lymphoma cases. Increases in cytological grade are a feature of the clinical progression of this malignancy, and eventual histologic transformation (HT) to the aggressive diffuse large B-cell lymphoma (DLBCL) occurs in up to 15% of patients. Clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Dreval, Kostiantyn, Hilton, Laura K., Cruz, Manuela, Shaalan, Haya, Ben-Neriah, Susana, Boyle, Merrill, Collinge, Brett, Coyle, Krysta M., Duns, Gerben, Farinha, Pedro, Grande, Bruno M., Meissner, Barbara, Pararajalingam, Prasath, Rushton, Christopher K., Slack, Graham W., Wong, Jasper, Mungall, Andrew J., Marra, Marco A., Connors, Joseph M., Steidl, Christian, Scott, David W., Morin, Ryan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644066/
https://www.ncbi.nlm.nih.gov/pubmed/37084389
http://dx.doi.org/10.1182/blood.2022018719
Descripción
Sumario:Follicular lymphoma (FL) accounts for ∼20% of all new lymphoma cases. Increases in cytological grade are a feature of the clinical progression of this malignancy, and eventual histologic transformation (HT) to the aggressive diffuse large B-cell lymphoma (DLBCL) occurs in up to 15% of patients. Clinical or genetic features to predict the risk and timing of HT have not been described comprehensively. In this study, we analyzed whole-genome sequencing data from 423 patients to compare the protein coding and noncoding mutation landscapes of untransformed FL, transformed FL, and de novo DLBCL. This revealed 2 genetically distinct subgroups of FL, which we have named DLBCL-like (dFL) and constrained FL (cFL). Each subgroup has distinguishing mutational patterns, aberrant somatic hypermutation rates, and biological and clinical characteristics. We implemented a machine learning–derived classification approach to stratify patients with FL into cFL and dFL subgroups based on their genomic features. Using separate validation cohorts, we demonstrate that cFL status, whether assigned with this full classifier or a single-gene approximation, is associated with a reduced rate of HT. This implies distinct biological features of cFL that constrain its evolution, and we highlight the potential for this classification to predict HT from genetic features present at diagnosis.